CLINICAL_TRIALS
trial_result
· 2009-10-28
Clinical Trial Update: Instillation of Gemcitabine in Patients With Superficial Bladder Cancer [Phase 3]
Summary
A Phase 3 trial evaluating intravesical gemcitabine for superficial bladder cancer was terminated, with results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Bladder Neoplasms | Phase 3 | Status: TERMINATED | Results posted: 2009-10-28